Emerald Health Issues Shares To Settle Debt With Subsidiary

Emerald Health Therapeutics (TSXV: EMH) is charging ahead with its previously announced shares for debt transaction with that of its partially owned subsidiary Emerald Health Sciences. The transaction is anticipated to reduce Emerald Health’s debts owed related to a loan as well as to trades payable.

In total, $2,816,963 in debt will be settled via the transaction, which will see 9,713,666 common shares of Emerald Health Therapeutics issued to Emerald Sciences at a price of $0.29. Of the total figure issued, $794,182 is related to a previously entered loan agreement whereas the remainder is in relation to trade payables.

Initially announced on December 16, the total figure of monies owed as well as shares issued has decreased marginally since the announcement. Whereas before 10.3 million shares were to be issued to Sciences as a means of settling $3.0 million in debt, those figures have decreased to the figures as described above. The result, is that Sciences will now own a total of 23.1% of the firm, rather than the previously anticipated 23.4%.

The transaction is subject to receiving regulatory approval. However, the independent members of Emerald Health’s Board of Directors have provided approval for the transaction.

Emerald Health Therapeutics last traded at $0.32 on the TSX Venture.


Information for this briefing was found via Sedar and Emerald Health Therapeutics. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Copper Juniors Could Explode After This Trade War Move | Christian Easterday – Hot Chili

Silver Is Rarer Than Gold, And the Market’s Waking Up | Shawn Khunkhun – Dolly Varden Silver

Gold Will Hit North of $4,000: Who’s Actually Producing? | Shane Williams – West Red Lake

Recommended

ESGold Sees ANT Survey Reveal Vertically Continuous System To 1,200 Metres Depth

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Related News

Village Farms Settles Dispute With Emerald Health, Acquires Majority Ownership In Pure Sunfarms

Village Farms (TSX: VFF) (NASDAQ: VFF) and Emerald Health Therapeutics (TSXV: EMH) have finally come...

Tuesday, March 3, 2020, 07:49:18 AM

Village Farms Joint Venture Pure Sunfarms Receives Sales License

Pure Sunfarms, the joint venture between Emerald Health Therapeutics (TSXV: EMH) and Village Farms (TSX:...

Monday, September 9, 2019, 08:53:54 AM

Emerald Health Reduces Workforce 33%, Replaces CFO

Emerald Health Therapeutics (TSXV: EMH) made it known to the public this morning that it...

Wednesday, October 30, 2019, 10:42:23 AM

Pure Sunfarms Top Brand In Ontario, Enters Alberta

Pure Sunfarms, the cannabis joint venture between that of Village Farms (TSX: VFF) (NASDAQ: VFF)...

Wednesday, February 26, 2020, 08:33:47 AM

Emerald Health Announces Exit From Cannabis Industry

And another one bites the dust. Emerald Health Therapeutics (CSE: EMH), one of the first...

Monday, November 29, 2021, 08:20:51 AM